Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 29

Sort by

Sort Order Select

Journal Articles

Nivolumab in Primary CNS Lymphoma and Primary Testicular Lymphoma with CNS Involvement: Single Center Experience

Andrey N. Gavrilenko, Nikita P. Volkov, Daniil I. Shmidt, Alexey Y. Polushin, Elena Kondakova, Kirill V. Lepik, Yuri R. Zalaylov, Marina O. Popova, MD PhD, Aleksandr D. Kulagin, MD PhD, Boris V. Afanasyev, Natalia B. Mikhailova, MD PhD

Blood (2020) 136 (Supplement 1): 4.

https://doi.org/10.1182/blood-2020-138924

Published: 2020

Journal Articles

Tumor Microenvironment in Patients with Relapsed/Refractory Classical Hodgkin Lymphoma before and after Anti-PD-1 Therapy

Artem A. Gusak, Kirill V. Lepik, Natalia B. Mikhailova, MD PhD, Elena Kondakova, Yuri R. Zalaylov, Marina O. Popova, MD PhD, Tatiana I. Ionova, Prof., Aleksandr D. Kulagin, MD PhD, Boris V. Afanasyev, Vadim Baykov

Blood (2020) 136 (Supplement 1): 27–28.

https://doi.org/10.1182/blood-2020-138858

Published: 2020

Journal Articles

Gvhd and Relapse Free Survival (GRFS) after Allogeneic Transplantation for Idiopathic Severe Aplastic Anemia: An Analysis from the Saawp Data Quality Initiative Program of EBMT

Blood (2020) 136 (Supplement 1): 3–4.

https://doi.org/10.1182/blood-2020-141757

Published: 2020

Journal Articles

Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT) with Different Intensity Conditioning Regimens in Children with Very High Risk Acute Lymphoblastic Leukemia (VHR ALL): A Single-Center Experience

Elena Vladimirovna Semenova, MD PhD, Olesia V Paina, PhD, Zhemal Zarifovna Rakhmanova, Dr., Polina Valerievna Kozhokar, Dr., Anastasia S Frolova, Dr, Kirill Alexandrovich Ekushov, Dr., Tatiana A Bykova, MD PhD, Anna Osipova, Inna V Markova, Dr., Sergey N. Bondarenko, PhDMD, Ildar Barhatov, Aleksandr Alyanski, Elena Babenko, Ivan S Moiseev, MD PhD, Ludmila S Zubarovskaya, MD PhD professor, Axel Zander, Boris V Afanasyev, MD PhD professor

Blood (2019) 134 (Supplement_1): 2050.

https://doi.org/10.1182/blood-2019-128163

Published: 2019

Journal Articles

Invasive Fungal Diseases Caused By Rare Pathogens in Large Cohort of Pediatric and Adult Patients after Hematopoietic Stem Cell Transplantation and Chemotherapy

Blood (2019) 134 (Supplement_1): 4497.

https://doi.org/10.1182/blood-2019-127961

Published: 2019

Journal Articles

Post-Transplant Cyclophosphamide after Matched Sibling, Unrelated and Haploidentical Donor Transplants in Patients with Acute Myeloid Leukemia, a Comparative Study of the ALWP EBMT

Jaime Sanz, MD PhD, Jaques-Emmanuel Galimard, Boris V Afanasyev, MD PhD professor, Emanuele Angelucci, MD, Fabio Ciceri, MD, Didier Blaise, MD PhD, Jan J Cornelissen, MD PhD, Ellen Meijer, MD PhD, José Luis Díez-Martín, MD PhD, Yener Koc, MD, Montserrat Rovira, Luca Castagna, MD, Bipin N. Savani, MD, Annalisa Ruggeri, MD, Mohamad Mohty, MD PhD, Arnon Nagler, MD MSc

Blood (2019) 134 (Supplement_1): 3274.

https://doi.org/10.1182/blood-2019-125859

Published: 2019

Journal Articles

Myeloablative Conditioning for First Allogeneic Hematopoietic Stem Cell Transplantation in Children with ALL: Total Body Irradiation or Chemotherapy? - a Multicenter EBMT-PDWP Study

Andre Manfred Willasch, MD, Christina Peters, MD, Petr Sedlacek, MD, Jean-Hugues Dalle, MD, Stelios Graphakos, MD, Akif Yesilipek, MD, Jacek Wachowiak, Prof MDPhD, Arjan Lankester, MD PhD, Arcangelo Prete, MD, Amir Ali Hamidieh, MD, Marianne Ifversen, Jochen Büchner, MDPhD, Gergely Krivan, MD, Rose-Marie Hamladji, MD, Cristina Diaz de Heredia, MD, Elena Skorobogatova, MD PhD, Gerard Michel, MD, Franco Locatelli, MD PhD, Alice Bertaina, MD PhD, Paul Veys, MD, Sophie Dupont, MD, Reuven Or, MD, Tayfun Guengoer, Olga Aleinikova, MD PhD, Sabina Sufliarska, MD, Mikael Sundin, MD PhD, Jelena Rascon, MD, Ain Kaare, MD, Damir Nemet, MD PhD, Franca Fagioli, MD, Thomas Klingebiel, MD, Jan Styczynski, PhD, Marc B Bierings, MDPhD, Kalman Nagy, MD, Manuel Abecasis, MD, Boris V Afanasyev, MD PhD Professor, Marc Ansari, MD, Arnaud Dalissier, Myriam Labopin, MD, Eric Beohou, Peter Bader, MD PhD

Blood (2017) 130 (Supplement 1): 911.

https://doi.org/10.1182/blood.V130.Suppl_1.911.911

Published: 2017

Journal Articles

Second Allogeneic Hematopoietic Stem Cell Transplantation for Post-Transplant Relapsed Acute Leukemia in Children - an EBMT PDWP Retrospective Study

Isaac Yaniv, MD, Aviva C. Krauss, MD, Eric Beohou, Arnaud Dalissier, Selim Corbacioglu, MD PhD, Marco Zecca, MD, Boris V Afanasyev, MD PhD Professor, Massimo Berger, MD, Miguel Angel Diaz, MD, Krzysztof Kalwak, MD, Petr Sedlacek, MD, Stefania Varotto, MD, Christina Peters, MD, Peter Bader, MD PhD

Blood (2017) 130 (Supplement 1): 912.

https://doi.org/10.1182/blood.V130.Suppl_1.912.912

Published: 2017

Journal Articles

Adoptive Cellular Therapy with Donor Lymphocyte Infusion Versus a Second Allogeneic Hematopoietic Cell Transplant for Post-Allograft Relapsed Acute Myeloid Leukemia: An Intent-to-Treat Analysis on Behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT)

Mohamed A Kharfan-Dabaja, MD, Myriam Labopin, MD, Emmanuelle Polge, Taiga Nishihori, MD, Ali Bazarbachi, MD PhD, Jürgen Finke, MD, Michael Stadler, MD PhD, Gerhard Ehninger, Bruno Lioure, MD, Nicolaas Schaap, Boris V Afanasyev, MD PhD Professor, Moshe Yeshurun, Cecilia Isaksson, Johan Maertens, Yves Chalandon, MD PhD, Christoph Schmid, Arnon Nagler, MD, Mohamad Mohty, MD PhD

Blood (2017) 130 (Supplement 1): 273.

https://doi.org/10.1182/blood.V130.Suppl_1.273.273

Published: 2017

Journal Articles

The Efficacy and Toxicity of Blinatumomab in Patients with Relapsed/Refractory Acute Lymphoblastic Leukemia: Russian Multicenter Experience

Blood (2017) 130 (Supplement 1): 2604.

https://doi.org/10.1182/blood.V130.Suppl_1.2604.2604

Published: 2017

Journal Articles

Regaining the Tumor Control in Relapsed/Refractory Hodgkin Lymphoma after Nivolumab Failure with Addition of Another Antineoplastic Agent

Nataliia Mikhailova, Kirill Lepik, Elena Kondakova, Evgeniya Borzenkova, Yuri Zalaylov, Andrey Kozlov, Vadim Baykov, Lilia Stelmakh, Luibov Tsvetkova, Olesya Smykova, Axel R Zander, MD PhD Professor, Boris V Afanasyev, MD PhD Professor

Blood (2017) 130 (Supplement 1): 1521.

https://doi.org/10.1182/blood.V130.Suppl_1.1521.1521

Published: 2017

Journal Articles

Post-Transplant Cyclophosphamide (PT-Cy) for Graft Versus Host Disease (GVHD) Prophylaxis in Allogeneic Transplantation from HLA Identical Sibling and Matched Unrelated Donor for Patients with Acute Leukemia, on Behalf of ALWP-EBMT

Annalisa Ruggeri, MD, Myriam Labopin, MD, Boris V Afanasyev, MD PhD Professor, Jan J Cornelissen, Ahmet Elmaagacli, MD, Maija Itälä-Remes, MD PhD, Didier Blaise, Ellen Meijer, Koc Yener, Noel Milpied, Harry C. Schouten, MD, Nicolaus Kröger, Mohamad Mohty, MD PhD, Andrea Bacigalupo, MD, Arnon Nagler, MD

Blood (2017) 130 (Supplement 1): 215.

https://doi.org/10.1182/blood.V130.Suppl_1.215.215

Published: 2017

Journal Articles

Hematopoietic Stem Cell Transplantation for Children with Neurological Diseases Improves the Outcomes and Not Leads to Significant Late Effects — Report from Russian Group

Kirill Kirgizov, MD PhD, Anastasia Borovkova, MD, Elena Skorobogatova, MD PhD, Tatjana Bykova, MD PhD, Alexey A Maschan, MD PhD Professor, Ludmila S Zubarovskaya, MD PhD Professor, Axel R. Zander, MD PhD Professor, Boris V Afanasyev, MD PhD Professor, Alexander Rumyantsev, MD PhD Professor

Blood (2017) 130 (Supplement 1): 4526.

https://doi.org/10.1182/blood.V130.Suppl_1.4526.4526

Published: 2017

Journal Articles

Graft-Versus-Host Disease Prophylaxis with Posttransplantation Cyclophosphamide and Ruxolitinib in Patients with Myelofibrosis

Elena V Morozova, MDPhD, Ivan S Moiseev, MD PhD, Maria V Barabanshikova, MDPhD, Elena I Darskaya, MDPhD, Sergey N. Bondarenko, PhDMD, Ludmila S Zubarovskaya, MD PhD Professor, Vadim Baykov, Alexandr L Alyanski, Ildar M Barkhatov, MD PhD, Axel R. Zander, MD PhD Professor, Boris V Afanasyev, MD PhD Professor

Blood (2017) 130 (Supplement 1): 4492.

https://doi.org/10.1182/blood.V130.Suppl_1.4492.4492

Published: 2017

Journal Articles

Interaction Between Center Effect and Strategy for Graft Vs. Host Disease Prophylaxis on Outcome of T-Cell Depleted and T-Cell Replete Haploidentical Transplants, an Analysis on Behalf of ALWP-EBMT

Lucie Biard, MDMSc, Myriam Labopin, Annalisa Ruggeri, MD, Fabio Ciceri, MD, Johanna Tischer, Boris V Afanasyev, Professor, Domenico Pastore, Donald Bunjes, Gerhard Ehninger, MD, Dietrich W. Beelen, Prof. Dr. MD, Mohamad Mohty, MD PhD, Arnon Nagler, Matthieu Resche-Rigon, MD PhD

Blood (2016) 128 (22): 3488.

https://doi.org/10.1182/blood.V128.22.3488.3488

Published: 2016

Journal Articles

Identification of Baseline Characteristics That Predict Good Outcome of Allogeneic Hematopoietic Cell Transplantation in Young Chronic Lymphocytic Leukemia Patients - a Retrospective Analysis from the Chronic Malignancies Working Party of the European Society for Blood and Marrow Transplantation.

Blood (2016) 128 (22): 522.

https://doi.org/10.1182/blood.V128.22.522.522

Published: 2016

Journal Articles

Bone Marrow Stromal Cells May Have Genetic Aberrations and Are Capable to Gain Them in a Culture

Ildar Barkhatov, MD PhD, Nikolai Tsvetkov, Elena Davydova, Alyona Shakirova, Alisa Potter, Ludmila S Zubarovskaya, Professor, Boris V Afanasyev, Professor

Blood (2016) 128 (22): 5061.

https://doi.org/10.1182/blood.V128.22.5061.5061

Published: 2016

Journal Articles

Comparable Results of Autologous and Allogeneic Hematopoietic Stem Cell Transplantation for Adult Patients with Philadelphia-Positive Acute Lymphoblastic Leukemia in First Complete Molecular Remission: An Analysis By the Acute Leukemia Working Party of the EBMT

Sebastian Giebel, Myriam Labopin, MD, Michael Potter, Xavier Poiré, MD, Henrik Sengeloev, MD, Gerard Socié, MD PhD, Anne Huynh, MD, Boris V Afanasyev, Professor, Urs Schanz, MD, Olle Ringden, Peter Kalhs, MD, Dietrich W. Beelen, Prof. Dr. MD, Antonio M. Campos, MD, Tamás Masszi, MD PhD, Mohamad Mohty, MD PhD, Arnon Nagler*, MD

Blood (2016) 128 (22): 512.

https://doi.org/10.1182/blood.V128.22.512.512

Published: 2016

Journal Articles

Allogeneic Hematopoietic Stem Cell Transplantation for Primary Refractory Acute Lymphoblastic Leukemia - a Report from the Acute Leukemia Working Party of the EBMT

Jiří Pavlů, Myriam Labopin, Johanna Tischer, Ioanna Sakellari, Matthias Stelljes, Jürgen Finke, Renato Fanin, Gernot Stuhler, Boris V Afanasyev, Professor, Adrian Bloor, Achilles Anagnostopoulos, Mohamad Mohty, Sebastian Giebel, Arnon Nagler

Blood (2016) 128 (22): 4668.

https://doi.org/10.1182/blood.V128.22.4668.4668

Published: 2016

Journal Articles

An EBMT Prospective Non-Interventional Study of Outcomes and Toxicity of Allogeneic Stem Cell Transplantation in Chronic Myeloid Leukemia Patients Previously Treated with Second Generation Tyrosine Kinase Inhibitors

Blood (2016) 128 (22): 628.

https://doi.org/10.1182/blood.V128.22.628.628

Published: 2016

NARROW

Nivolumab in Primary CNS Lymphoma and Primary Testicular Lymphoma with CNS Involvement: Single Center Experience

Tumor Microenvironment in Patients with Relapsed/Refractory Classical Hodgkin Lymphoma before and after Anti-PD-1 Therapy

Gvhd and Relapse Free Survival (GRFS) after Allogeneic Transplantation for Idiopathic Severe Aplastic Anemia: An Analysis from the Saawp Data Quality Initiative Program of EBMT

Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT) with Different Intensity Conditioning Regimens in Children with Very High Risk Acute Lymphoblastic Leukemia (VHR ALL): A Single-Center Experience

Invasive Fungal Diseases Caused By Rare Pathogens in Large Cohort of Pediatric and Adult Patients after Hematopoietic Stem Cell Transplantation and Chemotherapy

Post-Transplant Cyclophosphamide after Matched Sibling, Unrelated and Haploidentical Donor Transplants in Patients with Acute Myeloid Leukemia, a Comparative Study of the ALWP EBMT

Myeloablative Conditioning for First Allogeneic Hematopoietic Stem Cell Transplantation in Children with ALL: Total Body Irradiation or Chemotherapy? - a Multicenter EBMT-PDWP Study

Second Allogeneic Hematopoietic Stem Cell Transplantation for Post-Transplant Relapsed Acute Leukemia in Children - an EBMT PDWP Retrospective Study

The Efficacy and Toxicity of Blinatumomab in Patients with Relapsed/Refractory Acute Lymphoblastic Leukemia: Russian Multicenter Experience

Regaining the Tumor Control in Relapsed/Refractory Hodgkin Lymphoma after Nivolumab Failure with Addition of Another Antineoplastic Agent

Post-Transplant Cyclophosphamide (PT-Cy) for Graft Versus Host Disease (GVHD) Prophylaxis in Allogeneic Transplantation from HLA Identical Sibling and Matched Unrelated Donor for Patients with Acute Leukemia, on Behalf of ALWP-EBMT

Hematopoietic Stem Cell Transplantation for Children with Neurological Diseases Improves the Outcomes and Not Leads to Significant Late Effects — Report from Russian Group

Graft-Versus-Host Disease Prophylaxis with Posttransplantation Cyclophosphamide and Ruxolitinib in Patients with Myelofibrosis

Interaction Between Center Effect and Strategy for Graft Vs. Host Disease Prophylaxis on Outcome of T-Cell Depleted and T-Cell Replete Haploidentical Transplants, an Analysis on Behalf of ALWP-EBMT

Identification of Baseline Characteristics That Predict Good Outcome of Allogeneic Hematopoietic Cell Transplantation in Young Chronic Lymphocytic Leukemia Patients - a Retrospective Analysis from the Chronic Malignancies Working Party of the European Society for Blood and Marrow Transplantation.

Bone Marrow Stromal Cells May Have Genetic Aberrations and Are Capable to Gain Them in a Culture

Comparable Results of Autologous and Allogeneic Hematopoietic Stem Cell Transplantation for Adult Patients with Philadelphia-Positive Acute Lymphoblastic Leukemia in First Complete Molecular Remission: An Analysis By the Acute Leukemia Working Party of the EBMT

Allogeneic Hematopoietic Stem Cell Transplantation for Primary Refractory Acute Lymphoblastic Leukemia - a Report from the Acute Leukemia Working Party of the EBMT

An EBMT Prospective Non-Interventional Study of Outcomes and Toxicity of Allogeneic Stem Cell Transplantation in Chronic Myeloid Leukemia Patients Previously Treated with Second Generation Tyrosine Kinase Inhibitors

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only